Skip to content

Remopharma: what changed

BE 0806.560.542NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€241,142
2024 · €295,595-€54,453
Equity
€2.2m
2024 · €2.0m+€241,142
Cash
€233,124
2024 · €194,009+€39,114
Balance sheet total
€3.7m
2024 · €3.3m+€351,886

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€322,860

    up €322,860 (+19.0%), from €1.7m to €2.0m

    of which Plant, machinery and equipment: +€290,325

  • Receivables within one year +€77,634

    up €77,634 (+30.4%), from €255,574 to €333,208

    of which Trade receivables: +€80,720

  • Current investments -€75,000

    down €75,000 (-15.0%), from €501,222 to €426,222

  • Cash +€39,114

    up €39,114 (+20.2%), from €194,009 to €233,124

    mainly Net result for the year (+€241,142) and Depreciation (+€205,996)

Equity and liabilities
  • Reserves +€241,142

    up €241,142 (+12.3%), from €2.0m to €2.2m

    of which Distributable reserves: +€241,142

  • Trade debts +€181,473

    up €181,473 (+40.6%), from €447,431 to €628,904

  • Debts after one year -€86,835

    down €86,835 (-12.1%), from €716,145 to €629,311

Income statement
  • Gross operating margin +€136,903

    up €136,903 (+14.2%), from €965,347 to €1.1m

  • Staff costs +€126,016

    up €126,016 (+38.2%), from €329,855 to €455,871

  • Financial charges +€50,773

    up €50,773 (+82.2%), from €61,768 to €112,541

  • Depreciation +€26,702

    up €26,702 (+14.9%), from €179,294 to €205,996

  • Taxes -€24,839

    down €24,839 (-25.1%), from €99,124 to €74,285

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €295,595
Gross operating margin +€136,903
Staff costs -€126,016
Depreciation -€26,702
Other operating charges -€9,745
Financial income -€2,959
Financial charges -€50,773
Taxes +€24,839
Result 2025 €241,142
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€562,367
Investment -€428,456
Financing -€94,797
Cash 2024 €194,009
Net result for the year +€241,142
Depreciation +€205,996
Stocks and contracts -€9,705
Receivables within one year -€77,634
Deferred charges and accrued income -€2,973
Trade debts +€181,473
Tax, wage and social debts +€24,610
Smaller working-capital items -€542
Investment in fixed assets (net) -€503,456
Current investments +€75,000
Debts after one year -€86,835
Current portion of long-term debt -€7,962
Cash 2025 €233,124
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,311,547 €3,663,433 +€351,886 +10.6%
Fixed assets 21/28 €1,848,006 €2,145,466 +€297,460 +16.1%
Intangible fixed assets 21 €148,179 €122,779 -€25,400 -17.1%
Tangible fixed assets 22/27 €1,699,827 €2,022,687 +€322,860 +19.0%
Land and buildings 22 €1,128,351 €1,162,576 +€34,225 +3.0%
Plant, machinery and equipment 23 €553,225 €843,549 +€290,325 +52.5%
Furniture and vehicles 24 €18,252 €16,562 -€1,690 -9.3%
Current assets 29/58 €1,463,541 €1,517,967 +€54,426 +3.7%
Stocks and contracts in progress 3 €497,991 €507,696 +€9,705 +1.9%
Stocks 30/36 €497,991 €507,696 +€9,705 +1.9%
Amounts receivable within one year 40/41 €255,574 €333,208 +€77,634 +30.4%
Trade receivables 40 €220,225 €300,944 +€80,720 +36.7%
Other amounts receivable 41 €35,350 €32,264 -€3,086 -8.7%
Current investments 50/53 €501,222 €426,222 -€75,000 -15.0%
Cash at bank and in hand 54/58 €194,009 €233,124 +€39,114 +20.2%
Deferred charges and accrued income 490/1 €14,745 €17,718 +€2,973 +20.2%
Total equity and liabilities 10/49 €3,311,547 €3,663,433 +€351,886 +10.6%
Equity 10/15 €1,964,018 €2,205,160 +€241,142 +12.3%
Contributions 10/11 €1,000 €1,000 = 0.0%
Reserves 13 €1,963,018 €2,204,160 +€241,142 +12.3%
Tax-exempt reserves 132 €118 €118 = 0.0%
Distributable reserves 133 €1,962,900 €2,204,042 +€241,142 +12.3%
Amounts payable 17/49 €1,347,529 €1,458,273 +€110,744 +8.2%
Amounts payable after more than one year 17 €716,145 €629,311 -€86,835 -12.1%
Financial debts 170/4 €716,145 €629,311 -€86,835 -12.1%
Amounts payable within one year 42/48 €629,551 €827,712 +€198,161 +31.5%
Current portion of amounts payable after more than one year 42 €132,755 €124,793 -€7,962 -6.0%
Trade debts 44 €447,431 €628,904 +€181,473 +40.6%
Suppliers 440/4 €447,431 €628,904 +€181,473 +40.6%
Taxes, remuneration and social security 45 €49,280 €73,891 +€24,610 +49.9%
Taxes 450/3 €11,003 €18,138 +€7,134 +64.8%
Remuneration and social security 454/9 €38,277 €55,753 +€17,476 +45.7%
Other amounts payable 47/48 €85 €125 +€40 +47.1%
Accrued charges and deferred income 492/3 €1,832 €1,250 -€582 -31.8%
Remuneration, social security and pensions 62 €329,855 €455,871 +€126,016 +38.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €179,294 €205,996 +€26,702 +14.9%
Other operating charges 640/8 €14,266 €24,011 +€9,745 +68.3%
Gross operating margin 9900 €965,347 €1,102,250 +€136,903 +14.2%
Operating profit (loss) 9901 €441,932 €416,371 -€25,561 -5.8%
Financial income 75/76B €14,555 €11,596 -€2,959 -20.3%
Recurring financial income 75 €14,555 €11,596 -€2,959 -20.3%
Financial charges 65/66B €61,768 €112,541 +€50,773 +82.2%
Recurring financial charges 65 €61,768 €112,541 +€50,773 +82.2%
Profit (loss) for the period before taxes 9903 €394,719 €315,427 -€79,292 -20.1%
Income taxes 67/77 €99,124 €74,285 -€24,839 -25.1%
Profit (loss) for the period 9904 €295,595 €241,142 -€54,453 -18.4%
Profit (loss) for the period to be appropriated 9905 €295,595 €241,142 -€54,453 -18.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€2.0m to €2.4m

Midpoint €2.2m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €2.1m
Capitalised earnings €2.0m to €2.8m
Indication €2.0m to €2.4m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€2,205,160
Intangible fixed assets (21)
-€122,779
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€2.1m

Capitalised earnings

net result for the year (9904)
2025
€241,142
2024
€295,595
2023
€304,120
Average result
€280,286
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€2.0m / €2.3m / €2.8m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.